Studies have implicated chronic STING activation in the pathophysiology of autoimmune disorders, particularly those involving inflammatory responses to self-DNA (e.g., SLE, dermatomyopathies) [40552157]. This evidence concerns the gene STING1 and systemic lupus erythematosus.